These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11224101)

  • 1. Effects of the 5-HT3 antagonist ICS 205-930 on benzodiazepine withdrawal signs in rats.
    Leathley MJ; Goudie AJ
    Behav Pharmacol; 1992 Feb; 3(1):51-56. PubMed ID: 11224101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the 5-HT3 antagonist ondansetron on benzodiazepine-induced operant behavioural dependence in rats.
    Goudie AJ; Leathley MJ
    Psychopharmacology (Berl); 1992; 109(4):461-5. PubMed ID: 1365863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the 5-HT3 antagonist GR38032F (ondansetron) on benzodiazepine withdrawal in rats.
    Goudie AJ; Leathley MJ
    Eur J Pharmacol; 1990 Aug; 185(2-3):179-86. PubMed ID: 1979273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actions of ritanserin, a 5-HT(2/1C) antagonist, in benzodiazepine-dependent rats.
    Goudie AJ; Leathley MJ
    Behav Pharmacol; 1993 Jun; 4(3):247-255. PubMed ID: 11224192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the CCKB antagonist L-365, 260 on benzodiazepine withdrawal-induced hypophagia in rats.
    Goudie AJ; Leathley MJ
    Psychopharmacology (Berl); 1995 Mar; 118(1):57-64. PubMed ID: 7597123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the dependence potential of the selective 5-H1A agonist ipsapirone in rats and of its effects on benzodiazepine withdrawal.
    Goudie AJ; Leathley MJ
    Psychopharmacology (Berl); 1991; 103(4):529-37. PubMed ID: 1676531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the 5HT(1A) agonist anxiolytic gepirone on benzodiazepine withdrawal signs in rats.
    Goudie AJ; Leathley MJ
    Behav Pharmacol; 1991 Dec; 2(6):461-469. PubMed ID: 11224088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal.
    Prather PL; Rezazadeh SM; Lane JD; Rowan GA; Hooper ML; Lytle DA; Emmett-Oglesby MW; Lal H
    J Pharmacol Exp Ther; 1993 Feb; 264(2):622-30. PubMed ID: 8094750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the benzodiazepine-like dependence potential in rats of the putative 5-HT(1A) agonist anxiolytic S-20499.
    Goudie AJ; Leathley MJ; Cowgill J
    Behav Pharmacol; 1994 Apr; 5(2):131-140. PubMed ID: 11224261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal.
    Higgins GA; Nguyen P; Joharchi N; Sellers EM
    Psychopharmacology (Berl); 1991; 105(3):322-8. PubMed ID: 1839177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A liquid diet model of chlordiazepoxide dependence in mice.
    Chan AW; Leong FW; Schanley DL; Langan MC; Penetrante ML
    Pharmacol Biochem Behav; 1989 Dec; 34(4):839-45. PubMed ID: 2516328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The abilities of 5-HT3 receptor antagonist ICS 205-930 to inhibit alcohol preference and withdrawal seizures in rats.
    Kostowski W; Dyr W; Krzaścik P
    Alcohol; 1993; 10(5):369-73. PubMed ID: 8216882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ondansetron administration on opioid withdrawal syndrome observed in rats.
    Pinelli A; Trivulzio S; Tomasoni L
    Eur J Pharmacol; 1997 Dec; 340(2-3):111-9. PubMed ID: 9537805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT3 antagonist ICS 205-930 enhances naltrexone's effects on ethanol intake.
    Mhatre M; Pruthi R; Hensley K; Holloway F
    Eur J Pharmacol; 2004 May; 491(2-3):149-56. PubMed ID: 15140631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of the expression of sensitization and tolerance by ondansetron, a 5-HT3 receptor antagonist, administered during withdrawal from intermittent and continuous cocaine.
    King GR; Xiong Z; Ellinwood EH
    Psychopharmacology (Berl); 1998 Feb; 135(3):263-9. PubMed ID: 9498729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of physical dependence on diazepam by ondansetron in rats.
    Mizoguchi H; Shirayama N; Tsuda M; Yoshiike M; Suzuki T; Misawa M
    Life Sci; 1994; 54(9):PL131-6. PubMed ID: 8114607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial cross-dependence on ethanol in mice dependent on chlordiazepoxide.
    Chan AW; Langan MC; Leong FW; Penetrante ML; Schanley DL
    Pharmacol Biochem Behav; 1990 Feb; 35(2):379-84. PubMed ID: 2108449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 5-HT3 receptor antagonists on binding and function of mouse and human GABAA receptors.
    Klein RL; Sanna E; McQuilkin SJ; Whiting PJ; Harris RA
    Eur J Pharmacol; 1994 Jul; 268(2):237-46. PubMed ID: 7957645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT3 receptor antagonists reverse helpless behaviour in rats.
    Martin P; Gozlan H; Puech AJ
    Eur J Pharmacol; 1992 Feb; 212(1):73-8. PubMed ID: 1532555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models.
    Artaiz I; Romero G; Zazpe A; Monge A; Calderó JM; Roca J; Lasheras B; Del Río J
    Psychopharmacology (Berl); 1995 Jan; 117(2):137-48. PubMed ID: 7753959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.